Veritable, L.P. Viatris Inc Transaction History

Veritable, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$9.02 - $10.29 $243 - $277	-27 Reduced 0.13%	20,428 $203,000
Q1 2023 May 12, 2023	SELL	$9.2 - $12.26 $8,289 - $11,046	-901 Reduced 4.22%	20,455 $196,000
Q4 2022 Feb 14, 2023	BUY	$8.72 - $11.56 $12,007 - $15,918	1,377 Added 6.89%	21,356 $237,000
Q3 2022 Nov 14, 2022	SELL	$8.48 - $11.13 $69,841 - $91,666	-8,236 Reduced 29.19%	19,979 $170,000
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $5,303 - $6,539	533 Added 1.93%	28,215 $295,000
Q1 2022 May 11, 2022	BUY	$9.81 - $15.4 $12,978 - $20,374	1,323 Added 5.02%	27,682 $301,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $51,588 - $62,639	-4,267 Reduced 13.93%	26,359 $357,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $18,589 - $21,227	-1,403 Reduced 4.38%	30,626 $415,000
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $6,407 - $7,978	494 Added 1.57%	32,029 $458,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $28,240 - $38,526	-2,078 Reduced 6.18%	31,535 $441,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $480,665 - $629,907	33,613 New	33,613 $630,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.3B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.